Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
AZD4320 (AZD-4320)
AZD4320 (AZD-4320) is a BH3 mimetic and highly potent dual Bcl-2/Bcl-XL inhibitor with binding affinity in low nanomolar range similar to ABT-263 (Novitoclax), but with a better therapeutic index (lower toxicities) and amenable to I. V. administration (ref 1). It rapidly induces caspase-3 (CC3) cleavage and cell death in both Bcl-2-driven (SuDHL4, GI50 <50 nM) and Bcl-XL-driven (SuDHL8, GI50 <50 nM) diffuse large B-cell lymphoma (DLBCL) cell lines; Achieves complete and sustained (>24 days) tumor regressions in a mouse RS4;11 acute lymphocytic leukemia xenograft model (20 mg/kg, i.v.) (ref 1).
Catalog NO: CT-A4320
Synonym: AZD-4320
CAS NO: 1357576-48-7
Mol. Formula: C45H48ClF3N4O7S3∙1/2H2O
MW: 954.5
** in vivo Quality material. 99.9-100% by achiral and chiral HPLCs. A stereomerically pure single isomer (Clinically active isomer) with Verified Absolute Configuration (Ask for Data). Hemihydrate, validated by a Quantitative microanalysis. Bulk!! Prompt.